drugset / Trial / NCT03009916

Bileacid Malabsorption and GLP-1 Secretion

NCT03009916

Phase 4 Completed 24 enrolled University Hospital, Gentofte, Copenhagen
RandomizedCrossoverQuadruple-blindBasic science

Summary

The aim of this study is to examine the influence of BAM on postprandial GLP--1 secretion and glucose homeostasis, both with and without bile acid sequestration.

Timeline

Start
2016-03
Primary completion
2017-08-03
Completion
2017-08-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified 3750 mg